`
`Sent:
`
`To:
`
`CC:
`
`Mon May 08 2006 11:56:08 EDT
`
`sandrock/cambridge/biogen@biogenidec;f
`
`;carmen bozic/cambridge/biogen@biogenidec;
`
`
`
`
`;alfred
`
`
`
`;gilmore o'neill/cambridge/biogen@biogenidec;cara
`lansden/cambridge/biogen@biogenidec;minhua yang/cambridge/biogen@biogenidec;ratna
`lingamaneni/cambridge/biogen@biogenidec;tammy sarnelli/cambridge/biogen@biogenidec
`
`
`
`Subject:
`
`BG00012 EU briefing document for VP review
`
`Dear all,
`
`We will seek advice on BG00012 CDP from 4 EU Agencies (UK, Sweden, NL, and Spain) in
`June. As part of the scientific Advice procedure, we have prepared a briefing document, which is
`provided below for your review.
`
`
`
`
`
`
`I would be grateful if you could provide me with your comments by Friday 12 May. Your review
`of this briefing document would occur in parallel with the CTRB for BG00012 Phase 3 studies.
`
`With thanks and kind regards,
`
`Page 1 of 2
`
`Biogen Exhibit 2350
`Coalition v. Biogen
`IPR2015-01993
`
`
`
`
`
`Page 2 of 2
`
`Page 2 of 2